Clinical Trial

Research on Novel Biomarkers for Early Diagnosis of Parkinson's Disease:An Observational, Multicenter, Non-Randomized Controlled Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 16, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This observational, multicenter, non-randomized controlled study is to evaluate the detection ability of α-Synuclein Ultrafine Fluorescence Detection Method for body fluids (Such as saliva, urine, cerebrospinal fluid, and blood, etc.) and skin in Parkinson's patients.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-01-22; most recent amendment 2025-04-13.
Status change: Not Yet Recruiting → Recruiting 2024-11-05
Trial Details
NCT Number NCT06232772
Lead Sponsor Yousheng Xiao
Collaborators: The First Affiliated Hospital of Guangzhou Medical University, First Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, Guilin Medical College, Guangxi International Zhuang Medical Hospital
Conditions Parkinson's Disease
Enrollment 600 participants
Start Date 2024-03-31
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-04-16